MSD Netherlands Capital B.V., a subsidiary of Merck & Co., Inc., has announced the issuance of €3.4 billion in unsecured senior notes, guaranteed by Merck & Co., Inc. The offering includes four tranches with varying maturity dates: €850 million 3.250% notes due 2032, €850 million 3.500% notes due 2037, €850 million 3.700% notes due 2044, and €850 million 3.750% notes due 2054. The joint book-running managers for the issuance are Citigroup, BNP PARIBAS, and Deutsche Bank, with several co-managers also involved. The notes will be listed on the New York Stock Exchange, subject to approval. The proceeds from the offering are intended for general corporate purposes, which may include the repayment of existing indebtedness. The announcement was made on May 16, 2024, with the settlement expected to occur on May 30, 2024.

MSD Netherlands Capital B.V., a subsidiary of Merck & Co., Inc., has announced the issuance of €3.4 billion in unsecured senior notes, guaranteed by Merck & Co., Inc. The offering includes four tranches with varying maturity dates: €850 million 3.250% notes due 2032, €850 million 3.500% notes due 2037, €850 million 3.700% notes due 2044, and €850 million 3.750% notes due 2054. The joint book-running managers for the issuance are Citigroup, BNP PARIBAS, and Deutsche Bank, with several co-managers also involved. The notes will be listed on the New York Stock Exchange, subject to approval. The proceeds from the offering are intended for general corporate purposes, which may include the repayment of existing indebtedness. The announcement was made on May 16, 2024, with the settlement expected to occur on May 30, 2024.